Professor Michael Fehlings discusses the implications of his two papers in the Jan 2021 issue of The Lancet Neurology.

Read the full article:
https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(20)30407-5/fulltext

Emma Jones and Simon Mead discuss their article in The Lancet Neurology, identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease.

Mark Obermann discusses his study examining the use of prednisone for the short-term prevention of cluster headache.

Robert Innis discusses his work on measuring neuroinflammation using PET imaging.

Tom Solomon discusses his Rapid Review on neurologically-associated COVID-19 problems, in The Lancet Neurology.

Huda Zoghbi discusses the prospects for future therapies in Rett syndrome.

Bas Bloem chats about his new research into a network model for reshaping chronic neurological care for patients with Parkinson's disease.

Sarah Tabrizi discusses her new research into analysing the early onset of Huntington's Disease.

Meng-Chuan Lai discusses the current evidence base for supporting autistic people.

Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.